🍄 An octogenarian regains speech and memory after taking hallucinogenic mushrooms

The most astonishing clinical experience in neurology did not take place in a state-of-the-art laboratory, but with an 80-year-old American patient of Japanese origin, whose existence had been reduced to a few monosyllables and total dependence. This case, published in Frontiers in Neuroscience, challenges the certainty that cognitive loss in advanced dementia is irreversible.

Neurodegenerative diseases such as Alzheimer's are usually seen as an inexorable decline where memory, language, and independence gradually fade away. Yet this patient's story suggests that certain abilities, although inaccessible, may remain buried beneath the wreckage of the disease. A single dose of psilocybin, the active compound in hallucinogenic mushrooms, triggered a spectacular resurgence of her faculties.

A return to speech after five years of mutism

The patient had been living with Alzheimer's disease for a decade. For five years, she had produced only fragments of speech, suffered from incontinence, struggled to walk and swallow. Under medical supervision, she received 5 grams of psilocybin mushrooms, a high dose compared to typical clinical trials. The intervention did not follow any established protocol, due to the lack of data on severe dementia.

Approximately 19 hours after ingestion, the patient woke from a long sleep and began speaking spontaneously for nearly 4 hours. She recounted memories from her life, expressed emotions, and responded with humor. No serious adverse effects – prolonged agitation or cardiac issues – were observed during follow-up. This linguistic resurgence, though temporary, astonished those around her.

The study authors note that this intervention was purely exploratory. There is currently no validated dosing protocol for psilocybin in advanced dementia. The amount administered, high by standard measures, was chosen for the depth and duration of the desired effects. Despite this dose, no signs of prolonged agitation or cardiovascular instability were noted.

Sustained functional improvements over several weeks

In the days that followed, progress multiplied. The octogenarian regained continence after five years of chronic incontinence. She began walking independently again, dressing herself, making eye contact, and smiling at her loved ones. Her contextual memory and working memory, essential for social interactions, also improved.

One month later, a second dose of 3 grams was administered. The patient then described precise images, such as memories of surfing with her son on a peaceful island. The benefits persisted for several weeks, even though the disease itself did not regress. Doctors carefully avoid the term “recovery,” as the characteristic brain lesions of Alzheimer's remain present.

Psilocybin acts on serotonin 5-HT2A receptors, temporarily disrupting communication between major brain networks. In animals, it promotes the regrowth of neuronal extensions. According to the researchers, this reorganization may make previously dormant functions accessible.

This single case, however, does not allow for generalization of the results. The authors call for controlled trials to verify whether certain latent abilities can indeed be reactivated.